Spanner in works for Teva hostile takeover

It appears that Israeli pharmaceutical giant Teva has a battle on its hands in its hostile takeover of Dutch-based American rival Mylan.

Mylan’s independent foundation says it will exercise a call option allowing it to buy shares to control half the company in order to thwart the Teva maneuver. Mylan is a mass producer of generic drugs, and claims that one in 13 of all prescriptions in the US is filled by one of its products.

The American company’s foundation “formed its independent judgment that Mylan’s best interests are at risk as a consequence of the uncertainty and threats associated by a possible takeover by Teva,” says a Mylan statement.

Teva also tried unsuccessfully to acquire Mylan in April.

— AFP

Most Popular
If you’d like to comment, join
The Times of Israel Community.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.